1) metoprolol succinate
琥珀酸美托洛尔
1.
Preparation of metoprolol succinate pulsatile controlled-release pellets;
琥珀酸美托洛尔脉冲控释微丸的制备
2.
The formulation of metoprolol succinate sustained-released tablets was optimized using orthogonaldesign.
采用正交试验优化琥珀酸美托洛尔缓释片处方工艺,通过UV法测定体外释放度,HPLC测定犬体内血药浓度,进行体内外相关性研究。
2) Metoprolol succinate sustained-release tablets
琥珀酸美托洛尔缓释片
1.
Methods Ninety patients(pts) with carotid atherosclerotic were randomly divided into three groups(30 pts in each group): A group(metoprolol succinate sustained-release tablets group 47.
方法颈动脉粥样硬化患者90例,随机分为3组:A组(琥珀酸美托洛尔缓释片治疗组47。
3) metoprolol tartrate
酒石酸美托洛尔
1.
Preparation of metoprolol tartrate sustained-release pellets;
酒石酸美托洛尔缓释微丸的制备及处方因素考察
2.
Bioequivalence of metoprolol tartrate tablets in healthy volunteers;
酒石酸美托洛尔片在健康人体中的生物等效性研究
3.
Relative bioavailability of metoprolol tartrate extended release tablets;
酒石酸美托洛尔缓释片人体相对生物利用度研究
4) metoprolol fumarate
富马酸美托洛尔
1.
OBJECTIVE To prepare the explosion pulsatile-release tablets of metoprolol fumarate(MF) and to investigate the release characteristics in vitro.
目的以富马酸美托洛尔为模型药物,研制爆破型脉冲片并考察其体外释药特性。
5) Metoprolol
美托洛尔
1.
Synthesis of Metoprolol Catalyzed by Lewis Acid;
Lewis酸催化在合成美托洛尔中的应用
2.
Preparation of felodipine-metoprolol transdermal patch and its antihypertensive effects in spontaneously hypertensive rats;
非洛地平-美托洛尔复方透皮贴剂的研制及其药效实验研究
3.
Preparation and Absorption Property of Molecularly Imprinted Polymer for Metoprolol;
美托洛尔球形分子烙印聚合物的制备及吸附性能考察
6) betaloc
美托洛尔
1.
Clinic Observation on Blockade Betaloc and Enalapril in Treating Chronic Heart Failure;
美托洛尔与依那普利联合治疗慢性心力衰竭临床观察
2.
Effects of Betaloc on mRNA Expression of Calcium Release Channels of Myocardial Sarcoplasmic Reticulum in Dysfunctional Heart;
美托洛尔对心力衰竭大鼠心肌细胞肌浆网Ca~(2+)释放通道数量及其mRNA表达的影响
3.
Intravenous betaloc in termination of paroxysmal supraventricular tachycardia;
静脉注射美托洛尔治疗室上性心动过速疗效观察
补充资料：琥珀酸美托洛尔
分子式：2(C15H25NO3).C4H6O4
分子量：652.83
CAS号：98418-47-4
性质：
分子量：652.83
CAS号：98418-47-4
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条